Vischer and Setterwalls advised CombiGene on the deal. CombiGene AB and Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully...
You must be a Standard 1 Year member to access this content.
VISCHER advised the buyer on this transaction. Bär & Karrer acts as legal advisor to exceet Group in this transaction. A fund advised by AFINUM Management...
You must be a Standard 1 Year member to access this content.
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...
You must be a Standard 1 Year member to access this content.
